EW News and Press, Edwards Lifesciences Corporation From 07/30/21

Image source: The Motley Fool. Edwards Lifesciences Corporation (NYSE: EW) Q2 2021 Earnings Call Jul 29, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences Corporation (EW) Q2 2021 Earnings Call Tr...

Fisher’s 13F portfolio value increased from ~$142B to ~$159B in Q2 2021. The Vanguard Intermediate-Term Corporate Bond ETF stake was increased substantially this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~14% of the portfolio. F...

Edwards Lifesciences Corporation (EW) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and Chief Executive Officer Scott Ullem - Chief Financial Officer Conference Call Participants Bob Hop...

Edwards Lifesciences (NYSE:EW): Q2 Non-GAAP EPS of $0.64 beats by $0.09; GAAP EPS of $0.78 beats by $0.28. Revenue of $1.38B (+49.2% Y/Y) beats by $100M. TAVR sales exceeded expectations and grew 52 percent; underlying sales grew 48 percent. Continued progress on five pivotal trials in TMTT. ...

Edwards Lifesciences presents with the economic pillars that round out a robust investment case. Central to the sell-side's thesis is EW's valuation, which we firmly believe is justified at 46X earnings and 36X EBITDA. EW isn't the same business it was 2 or even 5 years ago, there...

Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR PR Newswire IRVINE, Calif. , July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that clinical and economic results from the 3M (multidisci...

Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021 PR Newswire IRVINE, Calif. , July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2021 after the market...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Demand for medical devices and equipment is rebounding following a pandemic-led decline last year as people deferred elective surgeries. This, coupled with their integration of advanced technologies and successful entry in new market segments, we think positions Intuitive (ISRG), Stryker (SYK...

Wedgewood Partners is a money manager founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. For Q2'21, our Composite (net) gained +11.8%. The S&P 500 Index gained +8.6%. The Russell 1000 Growth Index gained +11.9%. The Rus...